These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38283199)

  • 1. Engineered Exosomes Carrying miR-588 for Treatment of Triple Negative Breast Cancer Through Remodeling the Immunosuppressive Microenvironment.
    Zhang Z; Luo X; Xue X; Pang M; Wang X; Yu L; Qian J; Li X; Tian M; Lu A; Lu C; Liu Y
    Int J Nanomedicine; 2024; 19():743-758. PubMed ID: 38283199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer.
    Huang L; Rong Y; Tang X; Yi K; Qi P; Hou J; Liu W; He Y; Gao X; Yuan C; Wang F
    Mol Cancer; 2022 Feb; 21(1):45. PubMed ID: 35148751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.
    Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H
    Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-derived exosomal circPSMA1 facilitates the tumorigenesis, metastasis, and migration in triple-negative breast cancer (TNBC) through miR-637/Akt1/β-catenin (cyclin D1) axis.
    Yang SJ; Wang DD; Zhong SL; Chen WQ; Wang FL; Zhang J; Xu WX; Xu D; Zhang Q; Li J; Zhang HD; Hou JC; Mao L; Tang JH
    Cell Death Dis; 2021 Apr; 12(5):420. PubMed ID: 33911067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOD1-high fibroblasts derived exosomal miR-3960 promotes cisplatin resistance in triple-negative breast cancer by suppressing BRSK2-mediated phosphorylation of PIMREG.
    Li K; Lin H; Liu A; Qiu C; Rao Z; Wang Z; Chen S; She X; Zhu S; Li P; Liu L; Wu Q; Wang G; Xu F; Li S
    Cancer Lett; 2024 May; 590():216842. PubMed ID: 38582395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the influence of Human Umbilical Cord Mesenchymal Stem Cells-derived exosomes loaded with miR-3182 on metastatic performance of Triple Negative Breast Cancer cells.
    Khazaei-Poul Y; Shojaei S; Koochaki A; Ghanbarian H; Mohammadi-Yeganeh S
    Life Sci; 2021 Dec; 286():120015. PubMed ID: 34614416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery.
    Shadbad MA; Safaei S; Brunetti O; Derakhshani A; Lotfinejad P; Mokhtarzadeh A; Hemmat N; Racanelli V; Solimando AG; Argentiero A; Silvestris N; Baradaran B
    Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [JAG1 affects monocytes-macrophages to reshape the pre-metastatic niche of triple-negative breast cancer through LncRNA MALAT1 in exosomes].
    Xu M; Shi Y; Liu J; Wu M; Zhang F; He Z; Tang M
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Sep; 43(9):1525-1535. PubMed ID: 37814867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxic lung cancer cell-derived exosomal miR-21 mediates macrophage M2 polarization and promotes cancer cell proliferation through targeting IRF1.
    Jin J; Yu G
    World J Surg Oncol; 2022 Jul; 20(1):241. PubMed ID: 35897096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA HAND2-AS1 suppressed the growth of triple negative breast cancer via reducing secretion of MSCs derived exosomal miR-106a-5p.
    Xing L; Tang X; Wu K; Huang X; Yi Y; Huan J
    Aging (Albany NY); 2020 Dec; 13(1):424-436. PubMed ID: 33290256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel miRNA Targets and Therapies in the Triple-Negative Breast Cancer Microenvironment: An Emerging Hope for a Challenging Disease.
    Qattan A
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
    Chen LL; Zhang ZJ; Yi ZB; Li JJ
    Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasma exosomal miR-335-5p serves as a diagnostic indicator and inhibits immune escape in triple-negative breast cancer].
    Chen T; Dong Y; Wu X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Apr; 38(4):347-356. PubMed ID: 35583065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The stromal loss of miR-4516 promotes the FOSL1-dependent proliferation and malignancy of triple negative breast cancer.
    Kim JE; Kim BG; Jang Y; Kang S; Lee JH; Cho NH
    Cancer Lett; 2020 Jan; 469():256-265. PubMed ID: 31672492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomes derived from stem cells of human deciduous exfoliated teeth inhibit angiogenesis in vivo and in vitro via the transfer of miR-100-5p and miR-1246.
    Liu P; Zhang Q; Mi J; Wang S; Xu Q; Zhuang D; Chen W; Liu C; Zhang L; Guo J; Wu X
    Stem Cell Res Ther; 2022 Mar; 13(1):89. PubMed ID: 35241153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipocyte-derived exosomes promote the progression of triple-negative breast cancer through circCRIM1-dependent OGA activation.
    Li Y; Jiang B; Zeng L; Tang Y; Qi X; Wan Z; Feng W; Xie L; He R; Zhu H; Wu Y
    Environ Res; 2023 Dec; 239(Pt 1):117266. PubMed ID: 37775001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer.
    Liang G; Zhu Y; Ali DJ; Tian T; Xu H; Si K; Sun B; Chen B; Xiao Z
    J Nanobiotechnology; 2020 Jan; 18(1):10. PubMed ID: 31918721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-506-loaded gelatin nanospheres target PENK and inactivate the ERK/Fos signaling pathway to suppress triple-negative breast cancer aggressiveness.
    Liu XL; Liu WJ; Chen Q; Liu J; Yang CQ; Zhang G; Zhang SL; Guo WH; Li JB; Zhao G; Yin DC; Zhang CY
    Mol Carcinog; 2021 Aug; 60(8):538-555. PubMed ID: 34062009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.
    Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W
    BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocytes educated by cancer-associated fibroblasts secrete exosomal miR-181a to activate AKT signaling in breast cancer cells.
    Pakravan K; Mossahebi-Mohammadi M; Ghazimoradi MH; Cho WC; Sadeghizadeh M; Babashah S
    J Transl Med; 2022 Dec; 20(1):559. PubMed ID: 36463188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.